Searched for
INBRX 101
France's Sanofi to buy US drugs project INBRX-101 for about $2.2 billionFrench healthcare company Sanofi has agreed to buy drug development project INBRX-101 from parent company Inhibrx Inc for $2.2 billion. INB...
- Load More
France's Sanofi to buy US drugs project INBRX-101 for about $2.2 billionCapri Global eyes up to $500 million offshore bond issue
SBI raises $300 million under RBI's ECB swap window
India tops Taiwan to reclaim fifth spot in global market capitalisation
Goldman Sachs favours going long on 30-year govt bond
Leading Indian brokerages gear up to offer seamless access to global stocks via GIFT City
PRISM files IPO papers for Rs 6650 crore fresh issue, reports Rs 748 crore Profit in 9MFY26
US and Iran negotiators head to Doha, but meeting uncertain
NRI flows into Indian equities dip as compliance rules bite
ET Graphics: AI agents stealing IT’s lunch
IT deals face rejig as clients force new terms for AI gains
Indian AC makers eye Europe as record heatwaves spark export opportunity
ET Graphics: IT stacks up a homemade AI layer
Along came an alien prompt: A day in the life of a software engineer
Pi Ventures eyeing Fund-I exits as it plots third deeptech vehicle
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service